Dr Sharon Cohen joins touchNEUROLOGY to discuss the challenges in diagnosing Alzheimer’s disease (AD) at an early stage, the most exciting recent developments in diagnostic criteria, genetic testing, and neuroimaging techniques. Dr Cohen also talks through the recent developments in biomarker strategies for diagnosis and precision management of early AD.
The presentation entitled: ‘Accelerating Progress in Alzheimer’s Treatment. How Can we achieve timely, accurate, neuropathological diagnosis and precision management in early AD?’ was presented at the International Conference of Alzheimer’s and Parkinson’s diseases and related neurological disorders (AD/PD), 13-15 October 2021.
- What are the challenges in diagnosing Alzheimer’s disease (AD) at an early stage, and how can these be overcome? (0:20)
- What have been the most exciting recent developments in diagnostic criteria, genetic testing, neuroimaging techniques, and neurochemical assays? (1:23)
- What have we learned about biomarker strategies for diagnosis and precision management of early AD? (3:23)
Disclosures: Sharon Cohen is a consultant for but receives no personal fees from Alnylam, Biogen, Novo Nordisk, and RetiSpec; and receives grant/research support paid to institution from AgeneBio, Alector, Alnylam, Anavex, Biogen, Cassava Neurosciences, Eisai, Eli Lilly, Green Valley, Janssen, Novo Nordisk, RetiSpec, Roche, UCB Biopharma, and Vielight. Sharon Cohen is also on the advisory board (receives no personal fees) for Biogen, Cassava Neurosciences, Cognivue, Cogstate, Eisai, Eli Lilly, INmune Bio, ProMIS Neurosciences, and Roche.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch
Filmed as a highlight of AD/PD 2022
Share this Video
Related Videos In Alzheimer's Disease & Dementia
Kristen George, AAIC 2022: Experiences of discrimination on cognitive function and ageing among the oldest old: The LifeAfter90 (LA90) Study
The LifeAfter90 (LA90) Study aims to understand what cognitive ageing and dementia look like among individuals aged 90 and above. In this interview, Dr Kristen George (University of California Davis School of Medicine, University of California, Davis, CA, USA) discussed what the study found in terms of the effect of discrimination on the cognitive function of this […]
Claire Sexton: Highlights of AAIC 2022
The Alzheimer’s Association International Conference (AAIC) is the largest and most influential meeting dedicated to advancing Alzheimer’s and dementia research. Each year, it gathers researchers to share discoveries that’ll lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease. Dr Claire Sexton is the senior director of Scientific Programs […]
Dr Jennifer Bute: Living with dementia – the importance of laughter and hope
Dr Jennifer Bute is a retired GP living with dementia. She shares her experiences of diagnosis and describes the strategies that are helpful for her. Jennifer also highlights the importance of laughter, engagement and hope. Touch Medical Media is sharing educational resources on World Brain Day (22 July 2022) to help achieve brain health for […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!